The Federal Trade Commission (FTC) has sued Lunada Biomedical, Inc. and its owners over the dietary supplement Amberen®, alleging that the manufacturer falsely claimed the supplement was clinically proven to cause weight loss in women. FTC v. Lunada Biomedical Inc., No. 15-3380 (C.D. Cal., complaint filed May 12, 2015). Lunada marketed the product through radio and TV commercials, websites, email, and other promotional materials and reportedly sold nearly $65 million’s worth of the supplement between 2010 and 2013. FTC’s complaint alleges that the company’s clinical trials failed to demonstrate that the supplement caused weight loss and that the company falsely claimed that consumers could try the supplement at no cost for a month. Customers, however, received a 90-day supply and were required to return any unused product at their own expense to request a refund.